Want to dive into Scott Alexander's work and his thousands of blog posts? This fan website lets you sort and do semantic search through the whole codex. Enjoy!
| Date | ||
| Length | ||
| Likes | ||
| Comments |
Scott analyzes the implications of the FDA ending compounded GLP-1 weight loss drugs, which have provided a cheaper alternative to official channels for the past three years, and examines various responses from both compounding pharmacies and pharmaceutical companies.
Scott Alexander examines the surprisingly broad effects of GLP-1 drugs like Ozempic, exploring their mechanisms and speculating on why they seem to impact so many different conditions.
Read Scott like a free app: tap then Add to Home Screen. Read Scott like a free app: tap then Add app to Home screen. Add Read Scott Alexander to your home screen to read it like an app.